News From Montreal — Today at the international symposium data was presented on three preliminary clinical trials in England. The early trials are showing that a so-called therapeutic vaccine can boost the immune response in those infected with the hepatitis C virus.
Quoted from the article published today in the Vancouver Sun "Still, a viable vaccine is a decade away, said Paul Klenerman, a University of Oxford physician researcher who is conducting the trials. Other vaccine trials have been done already, but ours is the first where we're treating people (with drugs) and giving them the vaccine at the same time," he said.
.
.
No comments:
Post a Comment